APPENDICES - NIHR Health Technology Assessment Programme

More documents

Recommendations

Info

166 Appendix 9 photodynamic therapy and surgery for patients with non-small-cell lung cancer with pleural spread. J Clin Oncol 2004;22:2192–201. 14. Furuse K, Fukuoka M, Horai T, Hitomi S, Kato H, Hayata Y. Phase-II study of photodynamic therapy (PDT) with photofrin-II for hilar type early lungcancer. Photodyn Ther Biomed Lasers 1992;1011: 614–17. 15. Furuse K, Fukuoka M, Kato H, Horai T, Kubota K, Kodama N, et al. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. J Clin Oncol 1993;11:1852–7. 16. Kato H, Furukawa K, Sato M, Okunaka T, Kusunoki Y, Kawahara M, et al. Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. Lung Cancer 2003;42:103–11. 17. Moghissi K, Dixon K, Hudson E, Stringer M, Brown S. Endoscopic laser therapy in malignant tracheobronchial obstruction using sequential Nd YAG laser and photodynamic therapy. Thorax 1997;52:281–3. 18. Oakford M, Keohane SG. Photodynamic therapy to manage residual superficial basal cell carcinomas following Mohs’ surgery. Br J Dermatol 2004;151:96. 19. Okunaka T, Kato H, Tsutsui H, Ishizumi T, Ichinose S, Kuroiwa Y. Photodynamic therapy for peripheral lung cancer. Lung Cancer 2004;43:77–82. 20. Sutedja T, Baas P, Stewart F, van Zandwijk N. A pilot study of photodynamic therapy in patients with inoperable non-small cell lung cancer. Eur J Cancer 1992;28A:1370–3. 21. Tomaselli F, Maier A, Pinter H, Stranzl H, Smolle- Juttner FM. Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (clinical pilot study in 40 patients). Eur J Cardiothorac Surg 2001;19:549– 54. Case series (10 or more patients) 22. Ablitsov UA, Kuzin MI, Loginov LE, Uspensky LV. Photodynamic therapy of lung cancer. SPIE Proceedings Series 1995;2625:451–2. 23. Balchum OJ, Doiron DR, Huth GC. Photoradiation therapy of endobronchial lung cancers employing the photodynamic action of hematoporphyrin derivative. Lasers Surg Med 1984;4:13–30. 24. Balchum OJ, Doiron DR, Huth GC. HpD photodynamic therapy for obstructing lung cancer. Prog Clin Biol Res 1984;170:727–45. 25. Chida M, Handa M, Sato M, Matsumura Y, Okada Y, Shimada K, et al. [Re-evaluation of bronchoplasty for central-type lung cancer.] Nippon Geka Gakkai Zasshi 2001;102:530–4. 26. Chissov VI, Sokolov VV, Trakhtenberg AK, Mamontov AS. Photodynamic therapy of early stage cancer of lung, esophagus, and stomach with two different photosensitizers. SPIE Proceedings Series 1995;2625:466–75. 27. Cicenas S, Jackevicius A, Aleknavicius E, Bloznelyte L. Photodynamic therapy (PDT) in combined non small cell lung cancer (NSCLC) treatment. Radiother Oncol 1996;40:606. 28. Cortese DA, Edell ES, Kinsey JH. Photodynamic therapy for early stage squamous cell carcinoma of the lung. Mayo Clin Proc 1997;72:595–602. 29. Cortese DA, Kinsey JH. Endoscopic management of lung cancer with hematoporphyrin derivative phototherapy. Mayo Clin Proc 1982;57:543–7. 30. Cortese DA, Kinsey JH. Bronchoscopic phototherapy using hematoporphyrin derivative. Surg Clin North Am 1984;64:941–6. 31. Corti L, Toniolo L, Boso C, Colaut F, Fiore D, Muzzio P-C, et al. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma. Lasers Surg Med 2007;39:394–402. 32. Edell ES, Cortese DA. Bronchoscopic phototherapy with hematoporphyrin derivative for treatment of localized bronchogenic carcinoma: a 5-year experience. Mayo Clin Proc 1987;62:8–14. 33. Edell ES, Cortese DA. Photodynamic therapy: Treatment early stage lung cancer results and follow-up. Recent advances in bronchoesophagology. Proceedings of the 6th World Congress of Bronchoesophagology, Tokyo, Japan. Elsevier Science Publishers BV; 1990. pp. 205–10. 34. Edell ES, Cortese DA. Photodynamic therapy in the management of early superficial squamous cell carcinoma as an alternative to surgical resection. Chest 1992;102:1319–22. 35. Ernst A, Freitag L, Feller-Kopman D, LoCicero J, Ost D. Photodynamic therapy for endobronchial obstruction is safely performed with flexible bronchoscopy. J Bronchol 2003;10:260–3.
DOI: 10.3310/hta14370 Health Technology Assessment 2010; Vol. 14: No. 37 36. Freitag L, Ernst A, Thomas M, Prenzel R, Wahlers B, Macha HN. Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma. Thorax 2004;59:790–3. 37. Freitag L, Korupp A, Itzigehl I, Dankwart F, Tekolf E, Reichle G, et al. [Experiences with fluorescence diagnosis and photodynamic therapy in a multimodality therapy concept of operated, recurrent bronchial carcinoma.] Pneumologie 1996;50:693–9. 38. Fujimura S, Sakurada A, Sagawa M, Saito Y, Takahashi H, Tanita T, et al. A therapeutic approach to roentgenographically occult squamous cell carcinoma of the lung. Cancer 2000;89:2445–8. 39. Furukawa K, Kato H, Konaka C, Okunaka T, Usuda J, Ebihara Y. Locally recurrent central-type early stage lung cancer < 1.0 cm in diameter after complete remission by photodynamic therapy. Chest 2005;128:3269–75. 40. Furuse K, Okunaka T, Sakai H, Konaka C, Kato H, Aoki M, et al. [Photodynamic therapy (PDT) in roentgenographically occult lung cancer by photofrin II and excimer dye laser.] Gan To Kagaku Ryoho 1993;20:1369–74. 41. Grosjean P, Savary JF, Wagnieres G, Mizeret J, Woodtli A, Fontolliet C, et al. [Phototherapy of pharyngeal, oesophageal and bronchial early squamous cell carcinomas after sensitisation by tetra (m-hydroxyphenyl) chlorin (mTHPC).] Med Chir Digest 1996;25:411–13. 42. Grosjean P, Savary JF, Wagnieres G, Mizeret J, Woodtli A, Theumann JF, et al. Tetra(mhydroxyphenyl)chlorin clinical photodynamic therapy of early bronchial and oesophageal cancers. Lasers Med Sci 1996;11:227–35. 43. Harada M. [Recent advances in photodynamic therapy; an expanding role in non-small cell lung cancer.] Jpn J Lung Cancer 2005;45:687–92. 44. Hayata Y. Applications of laser photoradiation in the diagnosis and treatment of lung cancer. [Japanese]. Jpn Ann Thorac Surg 1983;3:203–10. 45. Hayata Y, Kato H, Furuse K, Fukuoka M. Photodynamic therapy in early stage lung cancer. In: Motta G, editor. Lung cancer: frontiers in science and treatment. Genoa, Italy: Rapallo; 1993. pp. 247–54. 46. Hayata Y, Kato H, Furuse K, Kusunoki Y, Suzuki S, Mimura S. Photodynamic therapy of 168 early stage cancers of the lung and oesophagus: a Japanese multi-centre study. Lasers Med Sci 1996;11:255–9. © 2010 Queen’s Printer and Controller of HMSO. All rights reserved. 47. Hayata Y, Kato H, Konaka C, Amemiya R, Ono J, Ogawa I, et al. Photoradiation therapy with hematoporphyrin derivative in early and stage 1 lung cancer. Chest 1984;86:169–77. 48. Hayata Y, Kato H, Konaka C, Okitsu H, Suga S, Sayami P. [Laser endoscopy in photodynamic therapy.] Chirurgie 1988;59:81–9. 49. Hayata Y, Kato H, Konaka C, Okunaka T. Photodynamic therapy (PDT) in early stage lung cancer. Lung Cancer 1993;9:287–93. 50. Hayata Y, Kato H, Konaka C, Ono J, Amemiya R, Kinoshita K, et al. Hematoporphyrin derivative and photoradiation therapy in early stage lung cancer. Lasers Surg Med 1984;4:39–47. 51. Hayata Y, Kato H, Konaka C, Ono J, Takizawa N. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer. Chest 1982;81:269–77. 52. Hayata Y, Yamamoto H, Kato H, Furukawa K. [Photodynamic therapy in early stage lung cancer using an excimer dye laser.] Nippon Rinsho 1990;48:201–7. 53. Hill HC, Nwogu CE, Loewen G, Pelow J, Dougherty TJ, Anderson TM. Off-label management of primary and metastatic endobronchial tumors with photodynamic therapy. Clin Pulmon Med 2004;11:107–11. 54. Hugh-Jones P, Gardner WN. Laser photodynamic therapy for inoperable bronchogenic squamous carcinoma. Q J Med 1987;64:565–81. 55. Imamura S, Kusunoki Y, Takifuji N, Kudo S, Matsui K, Masuda N, et al. Photodynamic therapy and/or external beam radiation therapy for roentgenologically occult lung cancer. Cancer 1994;73:1608–14. 56. Jones BU, Helmy M, Brenner M, Serna DL, Williams J, Chen JC, et al. Photodynamic therapy for patients with advanced non-small-cell carcinoma of the lung. Clin Lung Cancer 2001;3:37–41; discussion 2. 57. Karanov S, Kostadinov D, Shopova M, Kurtev P. Photodynamic therapy in lung and gastrointestinal cancers. J Photochem Photobiol B 1990;6:175–81. 58. Kato H, Harada M, Ichinose S, Usuda J, Tsuchida T, Okunaka T. Photodynamic therapy (PDT) of lung cancer: experience of the Tokyo Medical University. Photodiag Photodyn Ther 2004;1:49–55. 59. Kato H, Kawate N, Kinoshita K, Yamamoto H, Furukawa K, Hayata Y. Photodynamic therapy 167
Page 1 and 2: Appendices July 2010 10.3310/hta143
Page 3 and 4: DOI: 10.3310/hta14370 Health Techno
Page 9: DOI: 10.3310/hta14370 Health Techno
Page 12 and 13: 140 Appendix 6 18. Biel MA. Photody
Page 14 and 15: 142 Appendix 6 63. Gonzalez-Perez R
Page 16 and 17: 144 Appendix 6 treated with photody
Page 18 and 19: 146 Appendix 6 aminolevulinic acid
Page 20 and 21: 148 Appendix 6 carcinomas: 5 years
Page 40 and 41: 168 Appendix 9 of early-stage lung
Page 42 and 43: 170 Appendix 9 107. Okunaka T, Kato
Page 44 and 45: 172 Appendix 9 152. Kato H, Konaka
Page 54 and 55: 182 Appendix 12 as salvage treatmen
Page 56 and 57: 184 Appendix 12 63. Lorenz KJ, Maie
Page 58 and 59: 186 Appendix 12 107. Biel MA. Photo
Page 60 and 61: 188 Appendix 13 Study details Popul
Page 86 and 87: Appendix 13 214 Study details Popul
Page 89 and 90:
DOI: 10.3310/hta14370 Health Techno
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Study details Population details Tr
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153:
Page 156 and 157:
284 Appendix 21 Study details Popul
Page 158 and 159:
Appendix 21 286 Study details Popul
Page 162:
Feedback The HTA programme and the
show all

APPENDICES - NIHR Health Technology Assessment Programme

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?